Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
September 13 2021 - 4:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2021
HAPPINESS BIOTECH GROUP LIMITED
(Exact name of registrant as specified in its charter)
No. 11, Dongjiao East Road, Shuangxi, Shunchang,
Nanping City
Fujian Province, People’s Republic of
China
+86-0599-782-8808
(Address of Principal Executive Office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Annual General Meeting of Shareholders
In connection with the annual
meeting of shareholders of Happiness Biotech Group Limited, a Cayman Islands exempted company (the “Company”), the
Company hereby furnishes the following documents:
Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
Happiness Biotech Group Limited
|
|
|
|
Date: September 13, 2021
|
By:
|
/s/ Xuezhu Wang
|
|
|
Xuezhu Wang
Chief Executive Officer
|
2
Happiness Development (NASDAQ:HAPP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Happiness Development (NASDAQ:HAPP)
Historical Stock Chart
From Apr 2023 to Apr 2024